Should physicians give tPA to patients with acute ischemic stroke? For: thrombolytics in stroke: whose risk is it anyway?
Robinson
D J
DJ
Assistant Professor and Director of Research, Department of Emergency Medicine, University of Texas, Houston Health Science Center, PO Box 20708, Houston, TX 77225-0708, USA. David.J.Robinson@uth.tmc.edu
D002545:Brain Ischemia / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010348:Patient Care Team; D020127:Recovery of Function / Q000187:drug effects; D018570:Risk Assessment; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator